Impact of β-blockers on mortality in critically Ill patients with type 2 myocardial infarction: insights from a retrospective cohort study
β-blockers significantly reduce mortality in critically ill T2MI patients, supporting their use as a key treatment strategy for this population.
Authors
- Zhiliang Gao (ORCID: https://orcid.org/0000-0001-7611-4416)
- Haixiang Wang
- Chengcheng Wu
- Yongle Li (ORCID: https://orcid.org/0000-0001-9879-0626)
- Shanshan Tang (ORCID: https://orcid.org/0000-0001-5264-544X)
Institutions
- Tianjin Medical University General Hospital (CN)
Publication Details
- Journal
- Frontiers in Cardiovascular Medicine
- Published
- 2025-05-29
- DOI
- https://doi.org/10.3389/fcvm.2025.1531711
- Primary Topic
- Cardiac, Anesthesia and Surgical Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Massachusetts Institute of Technology